Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adoption and challenges of the 2018 International Society for Heart and Lung Transplantation consensus statement on adult and pediatric airway complications grading system in lung transplantation: A multicenter survey.

JHLT open·2026
Same author

Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19.

Pulmonary therapy·2026
Same author

Lung Transplantation in the Composite Allocation Score Era: Are Older Candidates Disadvantaged?

The Annals of thoracic surgery·2026
Same author

Assessing Preoperative Opioid Use and Outcomes in Patients With Cystic Fibrosis After Lung Transplantation.

The Journal of surgical research·2026
Same author

Predictors of in-hospital mortality among patients with cirrhosis and renal replacement therapy in the ICU: a retrospective cohort study.

Clinics and research in hepatology and gastroenterology·2026
Same author

Dexmedetomidine on supraventricular tachycardia in critical illness: a time-dependent propensity score matching study.

Critical care (London, England)·2026

相关实验视频

Updated: Jul 9, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

755

为肺移植候选人开发和验证初级移植功能障碍预测算法.

Joshua M Diamond1, Michaela R Anderson1, Edward Cantu2

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
|December 8, 2023
PubMed
概括

一个新的模型预测了肺移植后的初级移植功能障碍 (PGD) 风险. 该工具有助于供体选择和术后规划,改善患者的治疗结果和移植成功率.

关键词:
捐赠者 捐赠者 捐赠者 提供者肺部移植 肺部移植预测 预测 预测 预测主要的移植功能障碍.收件人的收件人是

更多相关视频

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

379
A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
07:37

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes

Published on: October 28, 2021

3.0K

相关实验视频

Last Updated: Jul 9, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

755
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

379
A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
07:37

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes

Published on: October 28, 2021

3.0K

科学领域:

  • 移植科学 移植科学
  • 医疗信息学 医疗信息学
  • 预测分析是一种预测分析.

背景情况:

  • 主要移植功能障碍 (PGD) 是肺移植后早期并发症和死亡的主要原因.
  • 准确的PGD风险预测对于优化供体选择和术后管理至关重要.
  • 需要一个可泛化和临床适用的PGD预测模型来支持移植决策.

研究的目的:

  • 开发一种临床上有用和可通用的预测模型,用于初级移植功能障碍 (PGD) 风险.
  • 在肺移植中创建一个实时PGD风险评估的用户界面.
  • 评估PGD预测模型的临床效用和净益.

主要方法:

  • 一项前性队列研究 (2012-2018) 用于推导PGD预测模型.
  • 规范化 (lasso) 后勤回归被用来确定重要的PGD预测因子.
  • 外部验证在一个中心进行,决策曲线分析评估模型效用.

主要成果:

  • 该PGD预测模型结合了供体和受体因素,包括距离,年龄,肺容量,LAS,BMI,肺动脉压力,性别,移植指示,供体特征和相互作用.
  • 一个用户界面可以实时对捐赠者-接受者对进行PGD风险评估.
  • 该模型证明了在导出和验证队列中的特定PGD风险范围的决策净收益.

结论:

  • 开发了一种具有临床价值的PGD预测算法,以帮助移植决策.
  • 该模型支持移植后护理规划,并可以为PGD治疗试验丰富患者队列.
  • 该工具通过提供准确的PGD风险分层,提高了肺移植接受者的管理.